ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...

Eli Lilly and Company (NYSE: LLY) today announced updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant), an oral estrogen receptor antagonist, in patients with estrogen receptor ...

"Your life is not over," Janine Geske told the 14-year-old in her courtroom. More than 30 years later, they're both trying to ...

We tested 25 indoor air quality monitors and picked the 9 best to help you detect pollutants and breathe cleaner air at home.

Combine Heterorhabditis nematodes (sold in paste-like form) with water and apply to the soil in the spring or fall. Wait a couple of days and reseed or replant any damaged areas. However, chemical ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine ...